Class Cert. Denied In Cephalon Painkiller Marketing Suit
A Pennsylvania federal judge on Monday refused to certify a proposed class action accusing drugmaker Cephalon Inc. of unjustly enriching itself by marketing a painkiller for off-label uses, ruling the plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article